144.46
-2.08(-1.42%)
Currency In USD
| Previous Close | 146.54 |
| Open | 145.7 |
| Day High | 150.56 |
| Day Low | 144 |
| 52-Week High | 211.13 |
| 52-Week Low | 113.5 |
| Volume | 1.13M |
| Average Volume | 589,750 |
| Market Cap | 8.09B |
| PE | -4,815.33 |
| EPS | -0.03 |
| Moving Average 50 Days | 143.77 |
| Moving Average 200 Days | 151.48 |
| Change | -2.08 |
If you invested $1000 in Repligen Corporation (RGEN) 10 years ago, it would be worth $6,955.22 as of December 21, 2024 at a share price of $144.46. Whereas If you bought $1000 worth of Repligen Corporation (RGEN) shares 5 years ago, it would be worth $1,558.02 as of December 21, 2024 at a share price of $144.46.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report
GlobeNewswire Inc.
Dec 12, 2024 12:30 PM GMT
WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2023 Corporate Sustainability Report and re
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns
GlobeNewswire Inc.
Dec 09, 2024 12:30 PM GMT
Breakthrough Innovation for the Purification of mRNA Therapeutics and VaccinesWALTHAM, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announ
Repligen Corporation to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
Nov 05, 2024 12:30 PM GMT
WALTHAM, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at three upcoming investor conferences. The UBS